The frequency of patient involvement in clinical practice guideline development in Japan: a descriptive study

ID: 

310

Session: 

Poster session 3

Date: 

Tuesday 18 September 2018 - 12:30 to 14:00

All authors in correct order:

Tsutsumi Y1, Tsujimoto Y2, Tsutsumi I3
1 Department of Emergency Medicine, National Hospital Organization Mito Medical Center, Ibaraki, Japan
2 Department of Nephrology and Dialysis, Kyoritsu Hospital, Hyogo, Japan
3 Department of Haematology, National Hospital Organization Mito Medical Center, Ibaraki, Japan
Presenting author and contact person

Presenting author:

Yasushi Tsujimoto

Contact person:

Yasushi Tsujimoto
Abstract text
Background:
The role of clinical practice guidelines (CPG) is to assist patients and medical practitioners and to improve the care of patients. Therefore, patient involvement in CPG development is recognized as an important issue around the world.

Objectives:
In this descriptive study, we aimed to identify how frequently current CPG in Japan involve patients as members of their development committees.

Methods:
We handsearched the Medical Information Network Distribution Service (MINDS) CPG registry to find eligible current guidelines. MINDS provides the largest CPG registry in Japan and is financially supported by the Japanese Ministry of Health, Labor and Welfare. We included CPG whose full-text was available via the MINDS website. We checked the full-text of each included CPG to confirm whether patients, family of patients or representatives of patient groups were credited as members of the development committees.

Results:
A total of 204 current Japanese CPG were available as full-text via the MINDS website. Of these, we excluded 12 because the affiliations of all or some of committee members were not stated in the full text of the guideline. As a result, we included 192 CPG in the analysis. Among them, 28 CPG (14.6%) had at least one patient member on the development committee. Of these, one CPG included members who were medical personnel as well as patient's family.

Conclusions:
The frequency of patient involvement in the CPG development is low in Japan. We propose that CPG development committees should promote patient involvement.

Patient or healthcare consumer involvement:
None.

Relevance to patients and consumers: 

The main focus of our study is to reveal the current situation of patient involvement in clinical practice guideline (CPG) development in Japan, which can be helpful to promote patient involvement.